Navigation Links
Cancer immunotherapy shows long-term promise in lung cancer
Date:4/24/2008

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery -- to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer -- the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months). MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

"The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3," explains Prof. Vansteenkiste. "In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells."

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

"Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer," says Prof. Vansteenkiste. "Postoperative chemotherapy is able to improve cure rates, but is someti
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
41-919-731-907
European Society for Medical Oncology
Source:Eurekalert

2

GOOD

Page: 1 2

Related biology news :

1. Researchers reveal structure of protein that repairs damage to cancer cells
2. Pregnancy is possible after cancer treatment
3. Effective cancer immune therapy through order in the blood vessels
4. Fox Chase researchers discover a method for clamping down on a cancer-promoting enzyme
5. Breast cancers behave differently before and after the age of 70
6. Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer
7. Ovarian cancer stem cells identified, characterized
8. Inherited cancer mutation is widespread in America
9. New type of drug shrinks primary breast cancer tumors significantly in just 6 weeks
10. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
11. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... complex systems like ecosystems can get messy, especially when ... unknowns like climate change. , In a new ... Proceedings of the National Academy of Sciences , researchers ... fundamental assumption at the very heart of a popular ... model how climate changes may impact biodiversity, researchers like ...
(Date:5/24/2013)... A frequently expressed concern in the ongoing public health ... especially those that are nutrient dense. A new ... Provide Most Nutrients Per Penny," published in the journal ... of the best nutritional values in the produce aisle, ... than most other raw vegetables and delivering one of ...
(Date:5/24/2013)... fastest growing open-access publishers, today announces the launch of ... A broad scope journal covering all specialties, Frontiers ... web platform for the research community to publish high ... and interactive peer-review enables fast, fair and constructive review ... of three months from submission to final decision for ...
Breaking Biology News(10 mins):Understanding the past and predicting the future by looking across space and time 2New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3
... 2008A study comparing breastfed and formula fed infants across ... are greater than the potential risks associated with infant ... present in breastmilk, according to a report published in ... Breastfeeding Medicine , a peer-reviewed journal published by Mary ...
... ability to view the activity of any chosen gene ... With GeneVision, military commanders could compare gene expression in ... to craving as shoppers moved about a store. "The ... his love-struck dates. Frightening? Perhaps. Ethically suspect? Certainly. ...
... researchers have developed the first natural, nontoxic method ... help diminish the environmental and health concerns that ... materials commonly used in products, from electronics to ... that carbon nanotubes deteriorate when exposed to the ...
Cached Biology News:Benefits of breastfeeding outweigh risk of infant exposure to environmental chemicals in breastmilk 2Real-time gene monitoring developed 2Pitt researchers create non-toxic clean-up method for potentially toxic nano materials 2
(Date:5/25/2013)... Dennis R. HIll M.D. Radiation Oncologist at the ... recently there has been a promotion of the idea that ... seed, or low dose rate, brachytherapy for prostate cancer. The ... a shorter half life, and gives a higher biologically effective ... has a higher average energy than the other commonly used ...
(Date:5/24/2013)... Dr. Ingrid Warmuth and Anamaria Newport, MHS, ... proud to announce an Open House at their Swedesboro location, ... June 8th from 10 AM to 2 PM. , ... and staff will be on hand to talk to people ... and provide complimentary cosmetic consultations. There will also be specials ...
(Date:5/24/2013)... Bellingham, WA (PRWEB) May 24, 2013 ... researchers, engineers, and industry suppliers will present technologies ... life at the annual SPIE Optics and ... August. Organized by SPIE, the international society ... the largest international, multidisciplinary optical sciences and technology ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Bed bug cases ... protect themselves from the looming higher risk of becoming the ... a new bed bug guideline. In the guide, the company ... and avoiding them while traveling. , According to ... an increase of bed bug infestation during summer: the warm ...
Breaking Biology Technology:Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 2Dennis R. Hill MD HDR Prostate Brachytherapy Specialist Compares Prostate Cancer Treatment Options: Not All Low Dose Rate Brachytherapy Isotopes Are the Same 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 2See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 3See What’s in Earth’s Future ? and Out in Space Now ? at SPIE Optics and Photonics 4Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 2Steps for Getting Rid of Bed Bugs without Using Chemicals and Avoiding Them While Traveling Enumerated by My Cleaning Products in Its Latest Post 3
... US Oncology, Inc . today announced that ... service, has exceeded the $15 million mark and has assisted more ... the launch of Care Advantage in August 2006. , , ... a positive resource to help so many cancer patients obtain lifesaving ...
... PLYMOUTH, Mass., July 9 Harvest Technologies Corp. ( ... sponsored 60-patient clinical trial conducted at Sri Ramachandra Medical ... to treat patients with non-reconstructable Critical Limb Ischemia (CLI) ... is a Harvard Medical international-associated institution based in Chennai, ...
... 9 Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), ... the appointment of Gary A. Lyons, to the Company,s board ... on the Poniard board to ten. , , "We ... us as we move toward our goal of commercializing picoplatin ...
Cached Biology Technology:OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 2OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 3OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 4Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 3
Donor feline serum and plasma...
Collected from sexually mature, mixed sex, mixed breed cats. Physiochemical constituents are measured to ensure lot-to-lot consistency....
Complete cell culture media with cytokines...
... available in single head (T2-04 SH) or twin ... portable air and gas applications. Delivering flow up ... environments where DC operation, high performance, low cost, ... Offers ultra-compact size, long life, and high efficiency. ...
Biology Products: